Translational Research & Medicine
Translational medicine focuses on turning biomedical discoveries into clinical solutions for both animals and people.
It is part of the growing One Health initiative—an approach dedicated to improving the lives of all species through
the integration of human medicine, veterinary medicine, and environmental science.
Examples of Translational Research & Medicine
- Dr. X. J. Meng, University Distinguished Professor of Molecular
Virology, studies the molecular mechanisms of viral replication and pathogenesis and develops vaccines against
emerging, reemerging, and zoonotic viral diseases, such as hepatitis E virus, porcine circovirus type 2, and
porcine reproductive and respiratory syndrome virus. Learn
- Dr. John Rossmeisl, associate professor of neurology and neurosurgery, develops new therapeutic techniques
to treat high-grade gliomas and other forms of brain cancer. He conducted a clinical trial on the use of electrical
fields to deliver cancer-fighting medication past the blood-brain barrier and is now overseeing another clinical
trial on the use of a type of targeted chemotherapy.
- Dr. Jennifer Barrett, the Theodora Ayer Randolph Professor of Equine Surgery, uses a variety of treatments, such
as stem cells and platelet-rich plasma, for lameness problems in both horses and dogs.
- Dr. Thomas Inzana, the Tyler J. and Francis F. Young
Professor of Bacteriology, has developed vaccines for swine pleuropneumonia and is working on one
for tularemia, an organism deemed a likely bioterrorism agent by the Centers for Disease Control
(CDC) in Atlanta.
- Former Dean Gerhardt Schurig developed the RB-51 vaccine which helped eradicate brucellosis, a disease that
affects animals and people, in the United States and is still in use today. Schurig and colleagues are conducting
ongoing research on the brucellosis vaccine.